This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jalathi S Nair: Innovator in Heterocyclic PAD4 Inhibitors
Introduction
Jalathi S Nair is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific enzyme activities.
Latest Patents
One of his notable patents is related to Heterocyclic PAD4 inhibitors. This patent involves substituted heterocyclic compounds of Formula (Ia), which serve as inhibitors of the PAD4 enzyme. The disclosure outlines methods for preparing these compounds, pharmaceutical compositions that include them, and their applications in treating diseases associated with PAD4 enzyme activity. Jalathi holds 1 patent in this area.
Career Highlights
Jalathi S Nair is currently associated with Bristol-Myers Squibb Company, where he continues to work on innovative solutions in drug development. His expertise in heterocyclic compounds has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Jalathi has collaborated with several professionals, including Kumaravel Selvakumar and Venkatram Reddy Paidi. These collaborations have further enhanced his research and development efforts.
Conclusion
Jalathi S Nair's work in the field of heterocyclic PAD4 inhibitors showcases his dedication to advancing pharmaceutical science. His contributions are vital for the development of new treatments for diseases linked to PAD4 enzyme activity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile